Patient: PARLA, RAVI KUMAR KUMAR Lab No: 2023-272280216
Reference #:
Age: 39 years Gender: M Patient ID: 2023272280216
Date of Birth: Jan 14 1984 Referring Site ID:
Address: 100 International Blvd.
HC #: 6324715181 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (905) 598-4725 Date of Service: Aug 16 2023 08:38
Telephone: (877) 849-3637
Reported on: Aug 16 2023 17:05 Toll Free: (877) 849-3637
Ordered by: DAWOOD DR. SHAMIM Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Comments
#5407
Reference Interval Note: Please note change in methodologies for routine
chemistry. Unless otherwise indicated, results
are equivalent and reference intervals remain
unchanged.
For a complete list of tests which have been
changed, please visit https://www.lifelabs.com
Hematology
WBC 6.7 4.0 - 11.0 x E9/L
RBC 5.20 4.50 - 6.00 x E12/L
Hemoglobin 150 135 - 175 g/L
Hematocrit 0.435 0.400 - 0.500 L/L
MCV 84 80 - 100 fL
MCH 28.8 27.5 - 33.0 pg
MCHC 345 305 - 360 g/L
RDW 13.1 11.5 - 14.5 %
Platelet Count 228 150 - 400 x E9/L
Differential
Neutrophils 3.3 2.0 - 7.5 x E9/L
Lymphocytes 2.6 1.0 - 3.5 x E9/L
Monocytes 0.5 0.2 - 1.0 x E9/L
Eosinophils 0.2 0.0 - 0.5 x E9/L
Basophils 0.1 0.0 - 0.2 x E9/L
Immature Granulocytes 0.0 0.0 - 0.1 x E9/L
Nucleated RBC 0 /100 WBC
NOTE: As of JuLY 4, 2023 LifeLabs' pediatric
reference ranges have been updated to reflect the
following published resource: Bohn, et al.
Int J Lab Hematol. 2020;00:1-11.
Biochemical Investigation of Anemias
Vitamin B12 148 138-652 pmol/L
Test repeated and results confirmed.
>220 pmol/L: Normal, deficiency unlikely
150-220 pmol/L: Borderline,deficiency is possible
<150 pmol/L: Low, consistent with deficiency
Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.
Page 1 of 3
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: PARLA, RAVI KUMAR KUMAR Lab No: 2023-272280216
Reference #:
Age: 39 years Gender: M Patient ID: 2023272280216
Date of Birth: Jan 14 1984 Referring Site ID:
Address: 100 International Blvd.
HC #: 6324715181 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (905) 598-4725 Date of Service: Aug 16 2023 08:38
Telephone: (877) 849-3637
Reported on: Aug 16 2023 17:05 Toll Free: (877) 849-3637
Ordered by: DAWOOD DR. SHAMIM Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
Glucose Fasting HI 7.1 3.6 - 6.0 mmol/L
Fasting Glucose greater than or equal to 7.0
mmol/L after an 8 hr fast can be used as a
provisional diagnosis of diabetes mellitus. If
asymptomatic, a repeat confirmation test using
Fasting Glucose, HbA1c, or 75g OGTT must be done.
Hemoglobin A1C/Total Hemoglobin HI 6.0 <6.0 %
Diabetes Canada 2018 Guidelines:
--------------------------------------------------
Screening and Diagnosis: < 5.5 % Normal
5.5% - 5.9 % At risk
6.0% - 6.4 % Prediabetes
>OR= 6.5 % Diabetes Mellitus
If HbA1c >OR= 6.5 % and asymptomatic, confirm
using Fasting Glucose, HbA1c or 75g OGTT.
--------------------------------------------------
Monitoring: <OR= 7.0 %
Target in adults without comorbidities. Other
targets may be more appropriate in children,
elderly and patients with comorbidities.
--------------------------------------------------
Results may not accurately reflect mean blood
glucose in patients with hemoglobin variants,
disorders associated with abnormal erythrocyte
turnover, severe renal and liver disorders.
Sodium 140 135-145 mmol/L
Potassium 4.4 3.5-5.2 mmol/L
Creatinine 95 67-117 umol/L
Glomerular Filtration Rate (eGFR) 87
An eGFR from 60-89 ml/min/1.73 m2 is consistent
with mildly decreased kidney function. However,
in the absence of other evidence of kidney
disease, eGFR values in this range do not fulfill
the KDIGO criteria for chronic kidney disease.
Interpret results in concert with ACR measurement.
Effective May 4 2015, eGFR is calculated using
the CKD-EPI 2009 equation.
KDIGO 2012 guidelines highlight the importance of
eGFR and urine albumin creatinine ratio (ACR) in
screening, diagnosis and management of CKD.
Results for eGFR should be interpreted in concert
with ACR.
Albumin 47 35-52 g/L
Bilirubin Total HI 25 <20 umol/L
Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.
Page 2 of 3
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
Patient: PARLA, RAVI KUMAR KUMAR Lab No: 2023-272280216
Reference #:
Age: 39 years Gender: M Patient ID: 2023272280216
Date of Birth: Jan 14 1984 Referring Site ID:
Address: 100 International Blvd.
HC #: 6324715181 Toronto, Ontario
Canada M9W 6J6
Patient's Phone: (905) 598-4725 Date of Service: Aug 16 2023 08:38
Telephone: (877) 849-3637
Reported on: Aug 16 2023 17:05 Toll Free: (877) 849-3637
Ordered by: DAWOOD DR. SHAMIM Fax: (905) 795-9891
Copy To:
Test Flag Result Reference Range - Units Lab Lic. #
General Chemistry
Alkaline Phosphatase 83 40-129 U/L
Alanine Aminotransferase 36 <50 U/L
Aspartate Aminotransferase 22 <35 U/L
Effective May 29, 2023 this test is performed on
a new analyzer; reported values might show up
to 14% increase. Reference intervals are
unchanged.
Lipids
Hours After Meal 12 Hours
Triglyceride HI 3.49 mmol/L
FASTING: <1.70 mmol/L
NON-FASTING: <2.00 mmol/L
Cholesterol 3.81 <5.20 mmol/L
Total cholesterol and HDL-C used for risk
assessment and to calculate non HDL-C.
HDL Cholesterol LO 0.76 >=1.00 mmol/L
HDL-C <1.00 mmol/L indicates risk for metabolic
syndrome.
Non HDL Cholesterol 3.05 <4.20 mmol/L
Non HDL-Cholesterol is not affected by the
fasting status of the patient.
LDL Cholesterol 1.77 <3.50 mmol/L
LDL-C is calculated using the NIH equation.
For additional LDL-C and non-HDL-C thresholds
based on risk stratification, refer to 2021 CCS
Guidelines. Can J Cardiol. 2021;37(8):1129-1150.
Effective May 29, 2023 please note a change in
decision limits that align with current clinical
guidelines. In addition, Friedevald LDL-C
equation is replaced by the new NIH LDL-C
equation that has improved accuracy when
triglycerides are high and/or LDL-C is low.
Cholesterol/HDL Ratio 5.0
Cholesterol/HDL-C is not included in the 2021 CCS
guideline as a lipid initiation or treatment
target but is recognized as an indicator of high
CVD risk at Cholesterol/HDL-C ratio >6.0
Lab - 5407: KENNEDY, 6560 Kennedy Road, Mississauga, Ontario.
Page 3 of 3
FINAL RESULTS
IMPORTANT: This report contains confidential information intended for view by authorized person(s) only and should be
disposed of securely (e.g. shredding) before discarding.
Note to Health Care Providers: This report has been printed by the patient.
Note to patients: Please contact your Health Care Provider if you have any questions regarding the results on this report.
